ProQR Therapeutics

PRQRNasdaq Netherlands Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$188.397 M

$1.34 -5.32%

Close of 6 Nov 2026

As of 6 Nov 2026, ProQR Therapeutics (PRQR) has a market capitalization of $188.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

105,361,064

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#249InflaRxIFRX$198.9M
#250Pyxis OncologyPYXS$193.1M
#251ProQR TherapeuticsPRQR$188.4M
#252Keros TherapeuticsKROS$187.6M
#253Entrada TherapeuticsTRDA$176.8M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of ProQR Therapeutics, worth $354.0K. Grants and option exercises are excluded.

Boer Daniel Anton DeChief Executive Officer$354.0K
200,000 shares at $1.77 on 31 Jul 2026 · filed 3 Aug 2026

What if ProQR Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$200,089.13

Per share 149,880× higher

Bitcoin $1.53T

$10,826.47

Per share 8,110× higher

Apple $5.02T

$35,542.31

Per share 26,623× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for ProQR Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.